BIOLOGICAL · Unmapped registry intervention
Sacituzumab Govitecan
Find medicine records ·
Find other trials using this name
Clinical trial
Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases
NCT04647916
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedTesting Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Anatomic Stage IV Breast Cancer AJCC v8unresolved
Interventions
Sacituzumab GovitecanBIOLOGICAL
Sponsors & collaborators
SWOG Cancer Research Networklead sponsor
National Cancer Institute (NCI)collaborator
Gilead Sciencescollaborator
Mapped research locations
DenverColorado, United States8Des MoinesIowa, United States6St LouisMissouri, United States4SeattleWashington, United States4CincinnatiOhio, United States4OmahaNebraska, United States4TucsonArizona, United States3LouisvilleKentucky, United States3DaytonOhio, United States3SpringfieldIllinois, United States3NashvilleTennessee, United States2ClevelandOhio, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04647916 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.